Globus Medical (BSP:G2ME34) Cyclically Adjusted Revenue per Share: R$0.00 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:G2ME34 Globus Medical Inc BSP:G2ME34
26 GF Score
Price R$52.00
GF Value R$58.52
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Globus Medical Cyclically Adjusted Revenue per Share?

Globus Medical BSP:G2ME34 26 Cyclically Adjusted Revenue per Share is R$0.00 as of Jun. 2026. GuruFocus rates BSP:G2ME34 with a GF Score™ of 26/100 and a GF Value™ of R$58.52 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Note: As Cyclically Adjusted Revenue per Share is a main component used to calculate Cyclically Adjusted PS Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation section below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Globus Medical's adjusted revenue per share for the three months ended in Jun. 2026 was R$29.451. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is R$0.00 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Globus Medical's average Cyclically Adjusted Revenue Growth Rate was 17.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 14.70% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 13.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Globus Medical was 14.70% per year. The lowest was 12.90% per year. And the median was 13.60% per year.

As of today (2026-08-11), Globus Medical's current stock price is R$52.00. Globus Medical's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was R$0.00. Globus Medical's Cyclically Adjusted PS Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Globus Medical was 12.34. The lowest was 4.64. And the median was 7.36.


Globus Medical  (BSP:G2ME34) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Globus Medical was 12.34. The lowest was 4.64. And the median was 7.36.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Globus Medical Cyclically Adjusted Revenue per Share Related Terms


Globus Medical Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Globus Medical's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Globus Medical Cyclically Adjusted Revenue per Share Chart

Globus Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Globus Medical Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BSP:G2ME34 vs PODD, BRKR, GKOS: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, Globus Medical's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Globus Medical Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Globus Medical's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Globus Medical's Cyclically Adjusted PS Ratio falls into.


BSP:G2ME34
26GF Score
Globus Medical Inc BSP:G2ME34
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Globus Medical Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Globus Medical's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=29.451/333.9520*333.9520
=29.451

Current CPI (Jun. 2026) = 333.9520.

Globus Medical Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 4.573 241.428 6.326
201612 5.268 241.432 7.287
201703 5.016 243.801 6.871
201706 5.134 244.955 6.999
201709 4.858 246.819 6.573
201712 5.875 246.524 7.959
201803 5.691 249.554 7.616
201806 6.441 251.989 8.536
201809 6.830 252.439 9.035
201812 7.501 251.233 9.971
201903 6.932 254.202 9.107
201906 7.384 256.143 9.627
201909 7.917 256.759 10.297
201912 8.440 256.974 10.968
202003 9.116 258.115 11.794
202006 7.924 257.797 10.265
202009 11.613 260.280 14.900
202012 11.842 260.474 15.183
202103 12.508 264.877 15.770
202106 12.198 271.696 14.993
202109 11.614 274.310 14.139
202112 13.568 278.802 16.252
202203 11.024 287.504 12.805
202206 12.935 296.311 14.578
202209 13.140 296.808 14.784
202212 14.088 296.797 15.852
202303 14.102 301.836 15.602
202306 13.906 305.109 15.221
202309 16.440 307.789 17.837
202312 21.881 306.746 23.822
202403 22.319 312.332 23.864
202406 24.760 314.175 26.319
202409 25.098 315.301 26.583
202412 28.702 315.605 30.371
202503 24.640 319.799 25.730
202506 30.282 322.561 31.351
202509 30.462 324.800 31.320
202512 33.015 324.054 34.023
202603 28.755 330.213 29.081
202606 29.451 333.952 29.451

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of R$0.00 mean?
Globus Medical (BSP:G2ME34) has a Cyclically Adjusted Revenue per Share of R$0.00 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Globus Medical and its competitors.
Is Globus Medical's Cyclically Adjusted Revenue per Share too high?
Globus Medical's current Cyclically Adjusted Revenue per Share is R$0.00. Overall, Globus Medical has a GF Score™ of 26/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Globus Medical's Cyclically Adjusted Revenue per Share compare to PODD and BRKR?
Globus Medical's Cyclically Adjusted Revenue per Share of R$0.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Globus Medical and its competitors. Globus Medical's current Cyclically Adjusted Revenue per Share is R$0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Globus Medical stock overvalued right now?
Based on GuruFocus' analysis, Globus Medical (BSP:G2ME34) is currently considered Modestly Undervalued. The stock's GF Value™ is R$58.52, compared to a current price of R$52.00 — trading 11.1% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is R$0.00. Globus Medical's overall GF Score™ is 26/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Globus Medical (BSP:G2ME34), the current Cyclically Adjusted Revenue per Share is R$0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Globus Medical (BSP:G2ME34) Overvalued in 2026?

Based on GuruFocus' analysis, Globus Medical stock appears to be undervalued. The current stock price of R$52.00 is trading 11.1% below its estimated GF Value™ of R$58.52. GuruFocus considers Globus Medical to be Modestly Undervalued.

Key valuation signals for BSP:G2ME34:

  • Cyclically Adjusted Revenue per Share: R$0.00
  • GF Value™: R$58.52 vs. price of R$52.00 (11.1% below fair value)
  • GF Score™: 26/100 with 5 warning signs

No single metric tells the full story. See the BSP:G2ME34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Globus Medical Business Description

Address 2560 General Armistead Avenue, Audubon, PA, USA, 19403
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
26GF Score

Get the complete analysis for BSP:G2ME34

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$52.00
Price
R$58.52
GF Value